RHENIUM-SCT

OncoBeta® GmbH is very proud to be a pioneer and innovator in the epidermal radioisotope sector, presently offering a therapeutic application for physicians to treat non-melanoma skin cancer. Future oriented, we seek, develop and deliver therapies which provide painless, customized, single-session applications that achieve exceptional cosmetic results... OncoBeta® GmbH with its headquarters located in Garching, near Munich, is a privately held medical device and radiochemical company specialized in the development and commercialization of state-of-the-art, innovative skin cancer therapies utilizing epidermal radioisotope applications. Since its foundation, OncoBeta® GmbH has concentrated its efforts on the development, regulatory approval(s) and commercialization of the epidermal radioisotope therapy Rhenium-SCT® (Skin Cancer Therapy), targeting non-melanoma skin cancers. Since then, OncoBeta® has successfully perfected the customized application and device management system in..

Registration numbers: HRB 185976 (W)

VAT numbers: DE271823356

Primary location: Garching Germany